Group treatment got them stable. Now they need a psychiatric prescriber who understands what they came out of, will not flinch at history, and will keep the medication continuity sustainable past the structure of the program.
i.Why this practice
ii.Harm reduction
For participants who need naloxone, syringe services, or peer support alongside clinical care, the practice points to local harm-reduction partners.
If your program coordinates referrals to this practice and you'd like to be in the conversation about formal partnership, call. Partnerships expand based on actual flow, not paperwork.
iii.The handoff
Quick call from a case manager
5-minute conversation confirms fit and capacity. Most participants seen within the same week.
Records welcomed, not required
Treatment summary from your program, if available, accelerates intake. If not, intake will gather the full picture.
Status update returned
With participant consent, you get a short clinical summary after intake. So your program can keep its part of the work coherent.
Continuity matters. The work you did sticks when the next prescriber understands what it took.